GALT short interest
Galectin Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 9,206,832 |
|---|---|
| Change vs prior report | -128,473 (-1.4%) |
| Change over six months | +35.4% |
| Days to cover | 33.66 (sector: 3.78) |
| Average daily volume | 273,539 |
| Rank in Healthcare | #3 of 922 by days to cover |
GALT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 9,206,832 | -1.4% | 33.66 | 273,539 |
| 2026-09-15 | 9,335,305 | +2.9% | 25.16 | 371,026 |
| 2026-08-31 | 9,075,436 | +0.8% | 33.35 | 272,112 |
| 2026-08-14 | 9,002,474 | +3.5% | 21.58 | 417,100 |
| 2026-07-31 | 8,696,498 | +2.4% | 23.63 | 367,988 |
| 2026-07-15 | 8,494,056 | -5.3% | 11.27 | 753,508 |
| 2026-06-30 | 8,972,735 | +14.1% | 4.87 | 1,841,200 |
| 2026-06-15 | 7,866,406 | +2.6% | 31.36 | 250,817 |
| 2026-05-29 | 7,663,672 | +4.1% | 19.71 | 388,753 |
| 2026-05-15 | 7,359,773 | -0.4% | 21.30 | 345,559 |
| 2026-04-30 | 7,388,749 | -1.0% | 24.71 | 299,033 |
| 2026-04-15 | 7,462,075 | +9.7% | 18.64 | 400,423 |
| 2026-03-31 | 6,801,737 | +3.6% | 29.29 | 232,219 |
| 2026-03-13 | 6,567,660 | +27.1% | 13.69 | 479,761 |
| 2026-02-27 | 5,169,383 | +1.5% | 26.67 | 193,806 |
| 2026-02-13 | 5,093,508 | +6.2% | 18.28 | 278,705 |
| 2026-01-30 | 4,797,622 | +1.0% | 15.18 | 316,060 |
| 2026-01-15 | 4,749,085 | -3.1% | 9.31 | 510,379 |
| 2025-12-31 | 4,902,530 | -17.6% | 5.50 | 890,925 |
| 2025-12-15 | 5,950,487 | -12.7% | 9.55 | 623,168 |
| 2025-11-28 | 6,816,789 | +0.9% | 23.08 | 295,373 |
| 2025-11-14 | 6,757,137 | -2.1% | 15.52 | 435,391 |
| 2025-10-31 | 6,903,772 | -17.7% | 19.84 | 348,046 |
| 2025-10-15 | 8,385,038 | +2.1% | 30.14 | 278,157 |
| 2025-09-30 | 8,212,706 | +2.1% | 35.42 | 231,839 |
import finzdata as yf
yf.Ticker("GALT").short_interest # every report since 2017
yf.Client().short_interest(["GALT"], start="2018-01-01")Healthcare short interest · GALT price history · Who owns GALT · All short interest